📋 Tender Overview
Contract awarded for Pharmaceutical products - medicines included in various national programs lot-0001, title: atezolizumab/conc.pt sol.perf.1200mg/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 1,050,861.60 lei, for which 0.9999% gp - 10,508.00 lei will be requested. lot-0002, title: bleomycin sulfate/pul.pt.sol.inj./perf.15000ui/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 10,883.40 lei, for which (0.9923%) gp - 108.00 lei will be requested. lot-0006, title: doxorubicin 50mg/sol.inj. (2mg/ml-25ml)/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 15,744.00 lei, for which (0.9972%) gp - 157.00 lei will be requested. lot-0007, title: gemcitabine 2g/conc.pt.sol.perf.2g/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 21,108.00 lei, for which (0.9996%) gp - 211.00 lei will be requested. lot-0012, title: trastuzumab emtasine 100mg/pulb.pt.con.pt.sol.perf. 100mg/5ml/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 303,744.00 lei, for which (0.9999%) gp - 3,037.00 lei will be requested. lot-0013, title: obinutuzumab 1g/ conc.pt sol.perf. 1000mg/40ml/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 383,555.88 lei, for which (0.9999%) gp - 3,835.00 lei will be requested. lot-0014, title: polatuzumab vedotin 30mg/pulb.pt.conc.pt.sol.perf 30mg/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 674,053.92 lei, for which (0.9999%) gp - 6,740.00 lei will be requested. lot-0015, title: polatuzumab vedotin 140mg/pulb.pt.conc.pt.sol.perf 140mg/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 1,045,889.28 lei, for which (0.9999%) gp - 10,458.00 lei will be requested. lot-0016, title: vinorelbine 50mg/vinorelbine teva 10mg/ml -5ml conc.pt.sol.perf. ct.1fl/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 12,666.24 lei, for which (0.9948%) gp - 126.00 lei will be requested. estimated value excluding vat: 24812.16 ron.Pharmaceutical products - medicines included in various national programs